CNS Pharmaceuticals, Inc. (CNSP) has 16 open-market insider trades by 7 insiders since 2020. Over the last six months insiders net bought $44K. The most active filer is Christopher Downs, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Christopher Downs | CFO | — | 6 | $364K | 2024-02-01 |
| Waldemar Priebe | 10% | — | 1 | $133K | 2023-03-28 |
| John M. Climaco | CEO | — | 3 | $65K | 2024-02-01 |
| Faith L. Charles | Dir | — | 1 | $34K | 2026-05-18 |
| Jerzy Gumulka | Dir | — | 3 | $20K | 2024-02-01 |
| Michal Fisher | Dir | — | 1 | $10K | 2026-05-18 |
| Carl Anthony Evans | Dir | — | 1 | $10K | 2024-02-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michal Fisher | Director | Buy | $10K | 2026-05-18 |
| Faith L. Charles | Director | Buy | $34K | 2026-05-18 |
| John M. Climaco | CEO | Buy | $50K | 2024-02-01 |
| Carl Anthony Evans | Director | Buy | $10K | 2024-02-01 |
| Christopher Downs | CFO | Buy | $20K | 2024-02-01 |
| Christopher Downs | CFO | Buy | $34K | 2023-08-22 |
Companies that share insiders with CNSP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John M. Climaco | CEO | Buy | $5K | 2023-08-16 |
| Jerzy Gumulka | Director | Buy | $4K | 2023-04-19 |
| Christopher Downs | CFO | Buy | $10K | 2023-04-17 |
| John M. Climaco | CEO | Buy | $10K | 2023-04-12 |
| Jerzy Gumulka | Director | Buy | $5K | 2023-04-10 |
| Waldemar Priebe | 10% | Sell | $133K | 2022-12-06 |
| Christopher Downs | CFO | Buy | $5K | 2021-12-06 |
| Christopher Downs | CFO | Buy | $5K | 2021-11-19 |
| Christopher Downs | CFO | Buy | $290K | 2020-08-24 |